Frequency of compound genotypes associated with ββ-blocker efficacy in congestive heart failure

Author： Lanfear David E   Marsh Sharon   Cresci Sharon   Spertus John A   McLeod Howard L  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.5, Iss.5, 2004-07, pp. : 553-558

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Perindopril: In Congestive Heart Failure

By Simpson D.   Noble S.   Goa K.L.  

Drugs, Vol. 62, Iss. 9, 2002-01 ,pp. : 1367-1377

Adis International

Access to resources Recommend Favorite

Bisoprolol for congestive heart failure

By Rosenberg Jens   Gustafsson Finn  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 2, 2008-02 ,pp. : 293-300

Informa Healthcare

Access to resources Recommend Favorite

Nesiritide for the treatment of congestive heart failure

By Iyengar Srinivas   Feldman David S   Trupp Robin   Abraham William T  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 4, 2004-04 ,pp. : 901-907

Informa Healthcare

Access to resources Recommend Favorite

Role of endothelins in congestive heart failure

By Moe Gordon W   Rouleau Jean L   Nguyen Quang T   Cernacek Peter   Stewart Duncan J  

Canadian Journal of Physiology and Pharmacology, Vol. 81, Iss. 6, 2003-06 ,pp. : 588-597

NRC Research Press

Access to resources Recommend Favorite

Safety of perioperative ββ-blocker use: how do ββ-blockers compare in terms of side effects?

By Ravensbergen Niels JC   Voute Michiel T   Poldermans Don  

Expert Opinion on Drug Safety, Vol. 10, Iss. 4, 2011-07 ,pp. : 545-558

Informa Healthcare

Access to resources Recommend Favorite